Final Decision – March 31, 2017

IPR2016-00006

STEADYMED LTD., (Petitioner)  v. UNITED THERAPEUTICS CORPORATION, (Patent Owner)

U.S. Patent No. 8,497,393 B2 “Process to Prepare Treprostinil, the Active Ingredient in Remodulin®”

Link to PDF: https://ptabdata.uspto.gov/ptab-api/documents/663936/native